Mark J. Holterman, Medical

IPSAC-VN Grants Scholarships to Vietnamese Medical Students

 

Scholarships pic
Scholarships
Image: ipsacvietnam.org

Mark J. Holterman, MD, is an established doctor focusing on surgery and pediatrics. Currently a professor at the University of Illinois College of Medicine, Dr. Mark Holterman is also a board member of TargaCell LLC., a biotech startup working with organ-specific delivery stem cells, and actively supports the International Pediatric Specialist Alliance for the Children of Vietnam (IPSAC-VN).

The International Pediatric Specialist Alliance for the Children of Vietnam (IPSAC-VN) is a non-profit organization that was established to address the surgical needs of children in Vietnam who are unable to attain the help they require. To accomplish its mission, the association partners with Vietnamese specialists and helps to provide the materials, educational resources, and outreach surgery needed.

Additionally, IPSAC-VN works to secure the future medical health of children in Vietnam through its international scholar program. The IPSAC Vietnam Scholarship Program is awarded to a licensed Vietnamese (or in-training) nurse, physician, or medical practitioner and provides them with the opportunity to study at an ACGME-accredited US institution. These institutions can include clinical practices, research institutions, various training regimes, and more, and they are individually tailored to the recipient of the scholarship.

Advertisements
Mark J. Holterman, Medical

Alliance for the Advancement of Cellular Therapeutics – Stem Cells

 

Alliance for the Advancement of Cellular Therapies pic
Alliance for the Advancement of Cellular Therapies
Image: aact.co

Mark J. Holterman, MD, is a professor of surgery and pediatrics at the University of Illinois College of Medicine. Dr. Mark J. Holterman is also involved in the emerging field of regenerative medicine and co-founded the Alliance for the Advancement of Cellular Therapies.

The Alliance for the Advancement of Cellular Therapeutics (AACT) works to expand medical knowledge of and patient access to cellular therapies. Cellular therapies involve the transplantation of human cells, which are used to regenerate tissue and treat a variety of difficult conditions.

Adult stem cells are integral to regenerative medicine and cellular therapies. When an injury occurs, stem cells cause tissue around the injury to begin the healing process. Stem cells naturally travel to areas where inflammation is present to facilitate this process, and physicians can now harvest these cells and reintroduce them where they are most needed artificially.

Adult stem cells differ from embryonic stem cells in that they come from the adult patient’s own body. In addition to alleviating certain ethical concerns, adult stem cells carry the benefits of being both abundant and cost effective in medicinal applications.